Clinical Trial Update: Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled trial evaluating omega-3 fatty acids for treating bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Depressive Disorder

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder, Involutional Depression | Phase 2 | Status: COMPLETED